We have a fantastic opportunity for an experienced Postdoctoral Immunologist - Coronavirus ELISA Specialist to play a key role in the Emerging Pathogens Vaccine Group's programme of work on coronavirus investigation and vaccine development. The primary focus will be to conduct detailed systems serology of pre-existing immunity to human coronaviruses in Children and Adults in UK and international samples.
You will have varied responsibilities including developing ELISAS for the assessment of coronavirus antibodies in clinical samples; standardising and validating assays for use; assisting with laboratory supervision and training of new students or junior research assistants in the group; collaborating with external partners in vaccine development and analysing data relating to the work undertaken.
You will have completed (or be close to completion of) your PhD in a relevant biological sciences subject and have practical experience with ELISA development. Delineation of detailed immunological profiling of humoral immune responses is desirable. Experience of standardizing assays will be beneficial.
You will have a keen interest in immunology of infectious diseases and excellent communication skills, including the ability to present data and represent research objectives at meetings. You will also be self-motivated, technically competent and capable of working independently in a laboratory with a responsible nature and a methodical and careful approach to working in the laboratory. Additionally you should have the ability to interpret scientific data, analyse and research complex issues and write factual reports. Excellent organisational and interpersonal skills including the ability to work closely with others as part of a team, while taking personal responsibility for assigned tasks, and managing multiple projects simultaneously is also essential.
Experience in human immunology/vaccine evaluation would be desirable, as would experience in international collaborative studies.
This post will provide invaluable experience and an opportunity to work in the international response to the COVID-19 pandemic and lay the foundation for development of future coronavirus vaccines.